SAA2 is known to be regulated by, and is, itself able to sustain inflammatory conditions in the brain, which in turn support resistance to TMZ and induce stem cell marker expression in GBM cells in vivo [54, 57]. This evidence concerns the gene SAA2 and glioblastoma.